Publications by authors named "Shereen Elazzazy"

Claim this Profile
S
Safety of immune checkpoint inhibitors for cancer treatment: real-world retrospective data analysis from Qatar (SAFE-ICI-Q study).
Nabil E Omar, Shereen Elazzazy, Anas Hamad, Mohamed Omar Saad, Aya Alasmar

Front Immunol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dihydropyrimidine Dehydrogenase Deficiency (DPYD) Genotyping-Guided Fluoropyrimidine-Based Adjuvant Chemotherapy for Breast Cancer. A Cost-Effectiveness Analysis.
Dina Abushanab, Shaban Mohamed, Rania Abdel-Latif, Diala Alhaj Moustafa, Wafa Marridi, Shereen Elazzazy

Clin Drug Investig· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of a clinical pharmacist-led multiple myeloma clinic with collaborative prescribing model at the national center for cancer care and research in Qatar.
Rola Ghasoub, Shereen Elazzazy, Maria Benkhadra, Nancy Kassem, Honar Cherif

J Am Pharm Assoc (2003)· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Data Presenting the Descriptive Analysis of the Use of Tyrosine Kinase Inhibitors (TKIs) Among Metastatic Non-Small-Cell Lung Cancer (mNSCLC) Patients in Qatar: A Nationwide Retrospective Cohort Study.
Rawan Dawoud, Harman Saman, Kakil Rasul, Farah Jibril, Arwa Sahal, Shereen Elazzazy

Clin Med Insights Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HER2-low non-metastatic breast cancer in Qatar-a nationwide retrospective cohort study to evaluate the response to neoadjuvant chemotherapy: a real-world analysis.
Ahmed Kardousha, Wafaa Shehada, Ahmed Basha, Sahar Nasser, Mufid El Mistiri, Shereen Elazzazy

Front Oncol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative cost-effectiveness analysis of CDK4/6 inhibitors in the first-line treatment of HR-positive and HER2-negative advanced breast cancer: a Markov's model-based evaluation.
Shereen Elazzazy, Nour Hisham Al-Ziftawi, Mohamed Izham Mohamed Ibrahim, Salha Bujassoum, Anas Hamad

Front Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effectiveness and safety of palbociclib and ribociclib in stage IV HR+/HER-2 negative breast cancer: a nationwide real world comparative retrospective cohort study.
Nour Hisham Al-Ziftawi, Shereen Elazzazy, Mohammed Fasihul Alam, Asrul Shafie, Anas Hamad

Front Oncol· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-COVID-19-associated multiorgan complications or "long COVID" with literature review and management strategy discussion: A meta-analysis.
Phool Iqbal, Fateen Ata, Hassan Chaudhry, Bassam Muthanna, Hafiz Waqas Younas, Shereen Elazzazy

Health Sci Rep· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Applying value-based strategies to accelerate access to novel cancer medications: guidance from the Oncology Health Economics Expert Panel in Qatar (Q-OHEP).
Anas Hamad, Shereen Elazzazy, Salha Bujassoum, Kakil Rasul, Javid Gaziev

BMC Health Serv Res· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness and Cost-Utility of Palbociclib versus Ribociclib in Women with Stage IV Breast Cancer: A Real-World Data Evaluation.
Nour Hisham Al-Ziftawi, Mohammed Fasihul Alam, Shereen Elazzazy, Asrul Akmal Shafie, Anas Hamad

Int J Environ Res Public Health· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tuberculosis following programmed cell death receptor-1 (PD-1) inhibitor in a patient with non-small cell lung cancer. Case report and literature review.
Aasir M Suliman, Shaza A Bek, Mohamed S Elkhatim, Ahmed A Husain, Ahmad Y Mismar, Shereen Elazzazy

Cancer Immunol Immunother· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and Management of Hematological Adverse Events Induced by Immune Checkpoint Inhibitors: A Systematic Review.
Nabil E Omar, Kareem A El-Fass, Abdelrahman I Abushouk, Noha Elbaghdady, Abd Elmonem M Barakat, Shereen Elazzazy

Front Immunol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Perceptions and expectations of health care providers towards clinical pharmacy services at a tertiary cancer centre in Qatar.
Nabil E Omar, Shereen Elazzazy, Oraib Abdallah, Abdulqadir J Nashwan, Yassin Eltorki

J Oncol Pharm Pract· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Law, Culture, and Fear: A Qualitative Study of Health Professionals' Perceptions of Narcotic Use Related to Cancer Pain.
Dania Al-Masri, Kerry Wilbur, Shereen Elazzazy, Azza A Hassan, Kyle J Wilby

J Pain Palliat Care Pharmacother· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of denosumab versus zoledronic acid on calcium levels in cancer patients with bone metastasis: A retrospective cohort study.
Sahar M Nasser, Arwa Sahal, Anas Hamad, Shereen Elazzazy

J Oncol Pharm Pract· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Practice implications of an antimicrobial stewardship intervention in a tertiary care teaching hospital, Qatar.
Ziad Nasr, Alya Babiker, Marwa Elbasheer, Aisha Osman, Shereen Elazzazy

East Mediterr Health J· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review of Clinical Outcomes Associated with Two Meropenem Dosing Strategies.
Kyle John Wilby, Ziad Ghantous Nasr, Shereen Elazzazy, Tim T Y Lau, Anas Hamad

Drugs R D· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Base deficit and serum lactate concentration in patients with post traumatic convulsion.
Ibrahim Afifi, Ashok Parchani, Hassan Al-Thani, Ayman El-Menyar, Raghad Alajaj, Shereen Elazzazy

Asian J Neurosurg· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical pharmacokinetics: perceptions of hospital pharmacists in Qatar about how it was taught and how it is applied.
Nadir Kheir, Ahmed Awaisu, Hoda Gad, Shereen Elazzazy, Farah Jibril

Int J Clin Pharm· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Grave Outcome of Posterior Reversible Encephalopathy Syndrome in a Patient Receiving Avastin (Bevacizumab) for Metastatic High-Grade Serous Ovarian Cancer.
Hind H Elmalik, Shereen ElAzzazy, Khaled S Salem, Salha Bujassoum

Case Rep Oncol· September 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cyclophosphamide-induced symptomatic hyponatremia, a rare but severe side effect: a case report.
Shereen Elazzazy, Asmaa Elhassan Mohamed, Amaal Gulied

Onco Targets Ther· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Point prevalence survey of antimicrobial utilization in oncology patients.
Arwa Hammuda, Sara Hayder, Shereen Elazzazy, Emily Black

J Infect Dev Ctries· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Toxic epidermal necrolysis associated with antiepileptic drugs and cranial radiation therapy.
Shereen Elazzazy, Taghrid Abu Hassan, Ashraf El Seid, Cicy Mary Jacob

Case Rep Oncol Med· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rhabdomyolysis secondary to drug interaction between atorvastatin, omeprazole, and dexamethasone.
Shereen Elazzazy, Saad S Eziada, Manal Zaidan

Int Med Case Rep J· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Severe hypophosphatemia induced after first cycle of the ESHAP protocol for Hodgkin's lymphoma: a case report.
Shereen Elazzazy, Hager A El-Geed, Sumaya Al Yafei

Int Med Case Rep J· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis